Jenburkt Pharmaceuticals Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 351.99 million compared to INR 282.9 million a year ago. Revenue was INR 364.55 million compared to INR 295.68 million a year ago. Net income was INR 63.54 million compared to INR 34.49 million a year ago. Basic earnings per share from continuing operations was INR 13.92 compared to INR 7.51 a year ago.
For the full year, sales was INR 1,367.49 million compared to INR 1,239.8 million a year ago. Revenue was INR 1,418.72 million compared to INR 1,289.29 million a year ago. Net income was INR 246.07 million compared to INR 222.97 million a year ago.